TONGHUA GOLDEN-HORSE(000766) 上海证券报·2025-03-27 19:25Summary of Key Points Core Viewpoint - Tonghua Jinma Pharmaceutical Group Co., Ltd. plans to secure a guarantee from its wholly-owned subsidiary Chengdu Yongkang Pharmaceutical Co., Ltd. for a credit loan application of up to RMB 55 million from Guangfa Bank, with a one-year term [3][16]. Group 1: Guarantee Overview - The company intends to apply for a credit loan not exceeding RMB 55 million for operational needs, with the subsidiary providing a guarantee for the principal and associated interest and fees [3][16]. - The board of directors approved the guarantee proposal with unanimous support, and it will be submitted for shareholder meeting approval [4][20]. Group 2: Company Information - Tonghua Jinma Pharmaceutical Group is registered in Tonghua City, Jilin Province, with a registered capital of RMB 966.494707 million and was established on February 26, 1993 [5]. - The company engages in the manufacturing of various pharmaceutical forms and the research and development of traditional Chinese medicine [5]. Group 3: Financial and Risk Assessment - After this guarantee, the total external guarantee amount will be RMB 1.705 billion, representing 73.57% of the company's audited net assets for 2023, all of which are guarantees for subsidiaries within the consolidated financial statements [8]. - The company has no overdue guarantees or litigation related to guarantees as of the announcement date [8]. Group 4: Board Meeting and Shareholder Meeting - The board meeting was held on March 27, 2025, with all eight directors present, and the meeting complied with relevant laws and regulations [11][12]. - A second extraordinary general meeting of shareholders is scheduled for April 15, 2025, to review the board's proposals [24][21].